[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO2010015I1 - Klopidogrel og acetylsalicylsyre eller famasøytiskaksepterbare salter derav - Google Patents

Klopidogrel og acetylsalicylsyre eller famasøytiskaksepterbare salter derav

Info

Publication number
NO2010015I1
NO2010015I1 NO2010015C NO2010015C NO2010015I1 NO 2010015 I1 NO2010015 I1 NO 2010015I1 NO 2010015 C NO2010015 C NO 2010015C NO 2010015 C NO2010015 C NO 2010015C NO 2010015 I1 NO2010015 I1 NO 2010015I1
Authority
NO
Norway
Prior art keywords
clopidogrel
pharmaceutically acceptable
pct
acceptable salts
acetylsalicylic acid
Prior art date
Application number
NO2010015C
Other languages
English (en)
Other versions
NO2010015I2 (no
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2010015(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO2010015I1 publication Critical patent/NO2010015I1/no
Publication of NO2010015I2 publication Critical patent/NO2010015I2/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO2010015C 1996-02-19 2010-07-09 Klopidogrel og acetylsalicylsyre eller famasøytiskaksepterbare salter derav NO2010015I2 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602027A FR2744918B1 (fr) 1996-02-19 1996-02-19 Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
PCT/FR1997/000296 WO1997029753A1 (fr) 1996-02-19 1997-02-17 Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique

Publications (2)

Publication Number Publication Date
NO2010015I1 true NO2010015I1 (no) 2010-07-26
NO2010015I2 NO2010015I2 (no) 2012-11-12

Family

ID=9489354

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19983812A NO317747B3 (no) 1996-02-19 1998-08-19 Farmasoytisk preparat samt anvendelse derav
NO2010015C NO2010015I2 (no) 1996-02-19 2010-07-09 Klopidogrel og acetylsalicylsyre eller famasøytiskaksepterbare salter derav

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19983812A NO317747B3 (no) 1996-02-19 1998-08-19 Farmasoytisk preparat samt anvendelse derav

Country Status (28)

Country Link
US (1) US5989578A (no)
EP (1) EP0881901B1 (no)
JP (1) JP3662028B2 (no)
KR (1) KR100295345B1 (no)
CN (1) CN1116042C (no)
AT (1) ATE218870T1 (no)
AU (1) AU715655B2 (no)
BR (1) BR9707556A (no)
CA (1) CA2246289C (no)
CZ (1) CZ292363B6 (no)
DE (2) DE122010000030I2 (no)
DK (1) DK0881901T3 (no)
EE (1) EE03513B1 (no)
ES (1) ES2176684T3 (no)
FR (1) FR2744918B1 (no)
HU (1) HU225036B1 (no)
IL (1) IL125848A (no)
IS (1) IS1892B (no)
NO (2) NO317747B3 (no)
NZ (1) NZ331444A (no)
PL (1) PL187292B1 (no)
PT (1) PT881901E (no)
RU (1) RU2184547C2 (no)
SI (1) SI0881901T1 (no)
SK (1) SK284285B6 (no)
TR (1) TR199801608T2 (no)
UA (1) UA51695C2 (no)
WO (1) WO1997029753A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045913A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
US6248729B1 (en) 1998-06-17 2001-06-19 Bristol-Myers Squibb Co. Combination of an ADP-receptor blocking antiplatelet drug and antihypertensive drug and a method for preventing a cerebral infarction employing such combination
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
EP1350511B1 (en) 2000-12-25 2008-09-10 Daiichi Sankyo Company, Limited Medicinal compositions containing aspirin
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
FR2832929A1 (fr) * 2001-12-05 2003-06-06 Sanofi Synthelabo Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
WO2004031143A2 (en) * 2002-10-02 2004-04-15 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
ES2378544T3 (es) * 2003-07-08 2012-04-13 Accumetrics, Inc. Activación selectiva de plaquetas para el seguimiento de terapia con antagonistas de ADP
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
HUP0400982A2 (en) * 2004-05-17 2006-08-28 Chemor Kutato New veterinary product for honeybees
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
RU2303980C2 (ru) * 2005-06-03 2007-08-10 ОАО "Щелковский витаминный завод" Лекарственная форма с антиагрегационным действием и способ ее изготовления
CN101253179B (zh) * 2005-09-21 2010-12-29 株式会社钟根堂 S-氯吡格雷的树脂酸盐复合物及其制备方法
WO2008048083A1 (es) * 2006-10-17 2008-04-24 Espinosa Abdala Leopoldo De Je Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de) 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
MX2009011619A (es) 2007-04-27 2010-01-18 Cydex Pharmaceuticals Inc Formulaciones que contienen clopidogrel y eter sulfoalquilico-ciclodextrina y metodos de uso.
JP2011512406A (ja) * 2008-02-22 2011-04-21 ハナル バイオファーマ カンパニー リミテッド 複合製剤
DE102008032361A1 (de) * 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
JP5808739B2 (ja) * 2009-05-13 2015-11-10 サイデックス・ファーマシューティカルズ・インコーポレイテッド プラスグレル及びシクロデキストリン誘導体を含む医薬組成物並びにその製造方法及び使用方法
KR20120050437A (ko) 2009-06-25 2012-05-18 테트라, 시아 신규한 아세틸살리실산 염들
WO2011071853A2 (en) 2009-12-07 2011-06-16 Academic Pharmaceuticals Incorporated Parenteral formulation of clopidogrel
CN102389436A (zh) * 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种抗血小板聚集的药物组合物
KR101675501B1 (ko) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en) 2011-11-26 2013-08-20 Academic Pharmaceuticals, Inc. Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
KR101473268B1 (ko) * 2012-03-09 2014-12-16 주식회사유한양행 클로피도그렐과 아스피린을 포함하는 약학 조성물 및 그의 제조방법
CN103720700A (zh) * 2012-10-10 2014-04-16 江苏威凯尔医药科技有限公司 含有阿斯匹林和维卡格雷的药用组合物
DK2796145T3 (da) 2013-04-22 2018-01-29 Csl Ltd Et kovalent kompleks af von Willebrand-faktor og faktor VIII linket af en disulfidbro
KR101502588B1 (ko) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
JP5905165B2 (ja) * 2013-08-02 2016-04-20 サノフイ アセチルサリチル酸およびクロピドグレルを含む医薬錠剤
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) * 2020-08-14 2021-03-31 Алексей Викторович Марочков Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
US20230059869A1 (en) 2021-08-03 2023-02-23 Liqmeds Worldwide Limited Oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
ATE218870T1 (de) 2002-06-15
CA2246289A1 (fr) 1997-08-21
NO983812L (no) 1998-10-09
DE69713287T2 (de) 2002-12-19
IS4827A (is) 1998-08-18
AU715655B2 (en) 2000-02-10
NO983812D0 (no) 1998-08-19
CA2246289C (fr) 2003-12-16
WO1997029753A1 (fr) 1997-08-21
FR2744918A1 (fr) 1997-08-22
CN1211922A (zh) 1999-03-24
JP3662028B2 (ja) 2005-06-22
NO317747B1 (no) 2004-12-13
HUP9901144A3 (en) 2001-04-28
HUP9901144A2 (hu) 1999-09-28
JPH11510818A (ja) 1999-09-21
UA51695C2 (uk) 2002-12-16
NO2010015I2 (no) 2012-11-12
HU225036B1 (en) 2006-05-29
FR2744918B1 (fr) 1998-05-07
IL125848A0 (en) 1999-04-11
PL187292B1 (pl) 2004-06-30
EP0881901A1 (fr) 1998-12-09
KR19990087163A (ko) 1999-12-15
NO317747B3 (no) 2011-10-03
DE122010000030I1 (de) 2010-10-21
DE122010000030I2 (de) 2012-06-21
SK284285B6 (sk) 2005-01-03
KR100295345B1 (ko) 2001-08-07
SK110598A3 (en) 1999-01-11
PT881901E (pt) 2002-09-30
CZ249998A3 (cs) 1998-11-11
DK0881901T3 (da) 2002-10-07
AU1884497A (en) 1997-09-02
EE9800247A (et) 1999-02-15
EP0881901B1 (fr) 2002-06-12
HK1017850A1 (en) 1999-12-03
ES2176684T3 (es) 2002-12-01
BR9707556A (pt) 1999-07-27
IL125848A (en) 2000-11-21
IS1892B (is) 2003-10-20
NZ331444A (en) 2001-04-27
US5989578A (en) 1999-11-23
SI0881901T1 (en) 2002-10-31
CN1116042C (zh) 2003-07-30
DE69713287D1 (de) 2002-07-18
RU2184547C2 (ru) 2002-07-10
PL327923A1 (en) 1999-01-04
EE03513B1 (et) 2001-10-15
CZ292363B6 (cs) 2003-09-17
TR199801608T2 (xx) 1998-11-23

Similar Documents

Publication Publication Date Title
NO2010015I1 (no) Klopidogrel og acetylsalicylsyre eller famasøytiskaksepterbare salter derav
FI942092A7 (fi) Hallitusti vapauttava valmiste
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
IL76932A0 (en) Pharmaceutical compositions containing dihydrocodeine and ibuprofen
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
PT862575E (pt) Novos derivados de geranilgeranilo processo para a sua preparacao e composicoes farmaceuticas relacionadas
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
DK0748222T3 (da) Hostestillende sammensætning, som indeholder hostestillende middel og benzydamin
NO985807D0 (no) Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament
DK513188D0 (da) Aminosyreestre, deres fremstilling og anvendelse som laegemidler
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
ITMI913511A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI922832A1 (it) DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO.
ITMI911653A0 (it) Derivati dell'eseridina ad attivita' amticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8819182A0 (it) Derivati dell'ambroxol,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI913512A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911444A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono